Markel — Financial Results
Insurance Underwriting Profitability Improved Sharply, Driven by a Better Combined Ratio
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Underwriting profit | $92.8M | $367.0M | $455.7M |
| Combined ratio | 98.8% | 95.5% | 94.6% |
| Earned premiums | $8.01B | $8.13B | $8.40B |
The combined ratio (the percentage of each premium dollar spent on claims and expenses — below 100% means a profit) improved from 98.8% in 2023 to 94.6% in 2025, meaning Markel's core insurance business is now generating a healthy underwriting profit. This was helped by lower losses on the discontinued IP CPI (intellectual property collateral protection insurance) product line and a continued pattern of favorable development on older reserves — meaning earlier claims are costing less than originally set aside. Premiums grew 3% in 2025, with strength in personal lines and international business partly offset by a deliberate exit from unprofitable directors and officers coverage.
The Markel Ventures Businesses Are Growing Revenue But Squeezing Margins
| Segment | 2025 Revenue | 2024 Revenue | 2025 Adj. Operating Income | 2024 Adj. Operating Income |
|---|---|---|---|---|
| Industrial | $3.93B | $3.78B | $343M | $365M |
| Financial | $737M | $593M | $327M | $262M |
| Consumer & Other | $1.38B | $1.33B | $175M | $145M |
The non-insurance businesses tell a mixed story. The Financial segment was the standout, with revenue up 24% and operating income up 25%, boosted by strong performance fees from insurance-linked securities management and a one-time $41M gain from selling a minority investment. The Industrial segment grew revenue 4% but saw operating income fall 6%, as higher materials and labor costs squeezed margins — particularly in industrial products. Consumer and Other grew modestly (4% revenue, 20% profit improvement), helped by an acquisition.
Intrinsic Value Per Share Has Compounded at About 15% Annually Over Five Years
Markel uses a proprietary measure of intrinsic value per share (a combined estimate of what the business is worth, using an earnings multiple plus balance sheet items like the equity portfolio and cash) to track long-term value creation. Using a 12x earnings multiple, the five-year compound annual growth rate was 15.2%. Share count has also declined from about 13,800 shares (in thousands) in 2020 to 12,590 in 2025, as the company has repurchased $430M of stock in 2025 alone, which adds to per-share value.
The Equity Investment Portfolio Remains a Powerful but Volatile Engine
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Equity portfolio fair value | $9.58B | $11.78B | $13.00B |
| One-year return on equities | 21.6% | 20.1% | 10.5% |
| Net investment income | $735M | $920M | $970M |
Markel holds a large portfolio of publicly traded stocks — think Berkshire Hathaway's approach. The portfolio grew to $13B in 2025, though the annual return of 10.5% was softer than the prior two years. Crucially, net investment income (the steady interest and dividends, not the volatile market gains) rose 5% to $970M, providing a reliable earnings stream. The cumulative unrealized gain in the equity portfolio is now $8.9B, which underpins a significant portion of Markel's balance sheet value.
Global Reinsurance Division Exited, Ending a Persistent Drag on Profitability
In August 2025, Markel sold the renewal rights for its Global Reinsurance division and placed it into run-off (meaning it will pay out existing claims but write no new business). The division had consistently hurt results — adding roughly one to two points to the combined ratio each year — and experienced adverse loss development in 2025 related to general liability claims being worse than expected on older policies. Exiting this business removes a recurring profitability headwind, though some residual claims costs will linger as policies wind down.